Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

32
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
32
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

21
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
21
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

10
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
10
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

12
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
12
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

9
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
9
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

12
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
12

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Angiography-Derived Index of Microcirculatory Resistance (Angio-IMR) Is Associated With Doppler-Derived Hyperemic Microvascular Resistance.

Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions·2026
Same author

Medical therapies to prevent the development and progression of calcific aortic valve stenosis: a contemporary review.

Expert review of cardiovascular therapy·2026
Same author

Peri-coronary inflammation and coronary microcalcification activity in subjects with diabetes mellitus; a cross-sectional analysis.

Journal of diabetes and its complications·2026
Same author

Artificial Intelligence-Based Frailty Assessment Outperforms Clinical Assessment in Predicting Outcomes After Transcatheter Aortic Valve Implantation.

Heart, lung & circulation·2026
Same author

Colchicine inhibits macrophage motility and matrix degradation through microtubule disruption.

Vascular pharmacology·2026
Same author

Inherited risk of coronary artery disease: redefining care with imaging and genetics.

Nature reviews. Cardiology·2026

Related Experiment Video

Updated: Jul 24, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K

Characteristics and Outcomes of Young Patients With ST-Elevation Myocardial Infarction Without Standard Modifiable

Ciaran Kelly1, Nick S R Lan2, Jane Phan1

  • 1Department of Cardiology, Fiona Stanley Hospital, Perth, Australia.

The American Journal of Cardiology
|July 9, 2023
PubMed
Summary

Young patients experiencing ST-elevation myocardial infarction (STEMI) without standard modifiable risk factors (SMuRFs) face significantly higher mortality. These SMuRF-less individuals are more prone to cardiac arrest and severe events, underscoring a need for targeted prevention.

More Related Videos

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.3K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.5K

Related Experiment Videos

Last Updated: Jul 24, 2025

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis
18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.3K
Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
05:26

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction

Published on: May 28, 2019

9.3K
Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
05:41

Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control

Published on: December 16, 2022

3.5K

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Standard modifiable risk factors (SMuRFs) include hypertension, diabetes mellitus, hypercholesterolemia, and smoking.
  • Patients with ST-elevation myocardial infarction (STEMI) lacking SMuRFs (SMuRF-less) exhibit worse short-term mortality.
  • The impact of being SMuRF-less on mortality in younger STEMI patients remains under-investigated.

Purpose of the Study:

  • To investigate the association between the absence of SMuRFs and mortality in young STEMI patients (aged 18-45 years).
  • To compare clinical outcomes and mortality rates between SMuRF-less and SMuRF-present young STEMI patients.

Main Methods:

  • Retrospective cohort study of 597 STEMI patients aged 18-45 years across 3 Australian hospitals (2010-2020).
  • Exclusion of nonatherosclerotic causes of STEMI.
  • Cox proportional hazards analysis to assess 30-day, 1-year, and 2-year all-cause mortality.

Main Results:

  • SMuRF-less patients (8.4%) were more likely to experience cardiac arrest (28.0% vs 12.6%), require vasopressors (16.0% vs 6.8%), mechanical support (10.0% vs 2.3%), and ICU admission (20.0% vs 5.7%).
  • Higher rates of left anterior descending artery infarcts were observed in SMuRF-less patients (62.0% vs 47.2%).
  • 30-day mortality was nearly fivefold higher in SMuRF-less patients (HR 4.70), a trend persisting at 1 and 2 years.

Conclusions:

  • Young STEMI patients without SMuRFs have significantly higher 30-day, 1-year, and 2-year mortality compared to those with SMuRFs.
  • Increased cardiac arrest rates and left anterior descending artery territory events may partially mediate this higher mortality.
  • Findings emphasize the need for enhanced prevention and management strategies for SMuRF-less STEMI in young individuals.